Detalhe da pesquisa
1.
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
J Infect Dis
; 225(11): 1923-1932, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35079784
2.
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.
J Infect Dis
; 220(3): 400-410, 2019 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30891607
3.
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines.
J Infect Dis
; 219(4): 544-555, 2019 01 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30304515
4.
Immunogenicity of a DNA vaccine candidate for COVID-19.
Nat Commun
; 11(1): 2601, 2020 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32433465
5.
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100.
Mol Ther Oncolytics
; 3: 16025, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-28054033
6.
Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device.
Hum Gene Ther Methods
; 26(4): 134-46, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26222896
7.
Direct transfection of dendritic cells in the epidermis after plasmid delivery enhanced by surface electroporation.
Hum Gene Ther Methods
; 25(6): 315-6, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25470335
8.
DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.
Mol Ther Methods Clin Dev
; 1: 14054, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-26052522
9.
Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
Hum Vaccin Immunother
; 9(10): 2041-8, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23954979
10.
Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.
Vaccines (Basel)
; 1(3): 384-97, 2013 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26344120